MedFirst (4175.TWO) monthly revenue, September 2026
MedFirst reported revenue of NT$0.66bn for September 2026, down 4.4% from the previous month and up 0.3% from a year earlier. Year-to-date revenue was NT$5.98bn, up 1.3% year on year. It ranked 108 of 159 companies in the Biotechnology and Medical Care industry by year-on-year growth.
| Month | Revenue NT$bn | MoM % | YoY % |
|---|---|---|---|
| September 2026 | 0.66 | -4.4 | 0.3 |